Novartis
Basel, Switzerland (U.S. headquarters: East Hanover, NJ)
Novartis is a global pharmaceutical company with a strong presence in immunology, oncology, ophthalmology, and gene therapy. Their immunology portfolio includes Cosentyx (secukinumab) and their rare disease unit offers transformative gene therapies. Novartis also has a growing biosimilar portfolio through Sandoz (now independent).
Drugs
Hub Program — Novartis Patient Assistance NOW
- ✓Insurance verification and benefits investigation
- ✓Prior authorization and appeals assistance
- ✓Copay programs for commercially insured patients
- ✓Novartis Patient Assistance Foundation (free medication)
- ✓Nurse educator and injection training support
Patient Assistance
Copay Assistance
Novartis offers copay savings for commercially insured patients on Cosentyx, Entresto, Kesimpta, and other products. Eligible patients may pay $0 or significantly reduced copays.
Patient Assistance Program (PAP)
Novartis Patient Assistance Foundation provides free Novartis medications to eligible patients who cannot afford treatment.
Denied a Novartis Drug?
Ellen can decode your denial, identify the specific reason, and generate a personalized appeal letter — free.